GRI Bio, Inc. - Common stock, par value $0.0001 per share (GRI)
Historical Holders from Q1 2025 to Q3 2025
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Symbol
-
GRI on Nasdaq
-
Shares outstanding
-
6,781,552
-
Price per share
-
$2.06
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Total 13F shares as of 30 Sep 2025
-
134,385
-
Total reported value
-
$276,832
-
% of total 13F portfolios
-
0%
-
Share change
-
+114,749
-
Value change
-
+$236,164
-
Avg buy value change
-
+0%
-
Avg sell value change
-
0%
-
Number of holders
-
8
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Significant Owners of GRI Bio, Inc. - Common stock, par value $0.0001 per share (GRI) based on Schedule 13D/G filings
| Filer |
Ownership |
Change % |
Holdings Value |
Net Change |
Nb Shares |
Change % |
Reporting Name |
Report Period |
|
Lincoln Alternative Strategies LLC
|
12%
|
|
$2,503,308
|
|
1,197,755
|
|
Lincoln Alternative Strategies LLC
|
12 Dec 2025
|
|
INTRACOASTAL CAPITAL, LLC
|
10%
|
+100%
|
$1,415,927
|
+$1,331,781
|
677,477
|
+1583%
|
Mitchell P. Kopin
|
11 Dec 2025
|
As of 30 Sep 2025,
GRI Bio, Inc. - Common stock, par value $0.0001 per share (GRI) has
8
institutional shareholders
filing 13F forms.
They hold
134,385 shares.
of 6,781,552
outstanding shares (2%)
.
Institutional Holders of GRI Bio, Inc. - Common stock, par value $0.0001 per share (GRI) across Reporting Periods
| Period |
Reported Shares, Excl. Options
|
Value, Excl. Options
|
Value Change
|
Puts Notional Value
|
Calls Notional Value
|
Price (% of par)
|
Investors
|
|
2025 Q3
|
134,385
|
$276,832
|
+$236,164
|
|
|
206%
|
8
|
|
2025 Q2
|
19,636
|
$25,331
|
+$19,075
|
|
|
129%
|
5
|
|
2025 Q1
|
4,850
|
$15,520
|
+$15,520
|
|
|
320%
|
5
|